About our products
Conditions we Treat
At Thrive Medical Cannabis Center, we support patients across a wide range of conditions where medical cannabis can play a critical role in symptom management, healing, and improved quality of life.
Pain Management
Chronic pain (back, neck, joint, and muscle pain)
Neuropathic pain (nerve pain, diabetic neuropathy)
Fibromyalgia
Arthritis (Osteoarthritis, Rheumatoid arthritis)
Mental Health Support
Anxiety disorders (GAD, PTSD, social anxiety)
Depression (as part of a broader treatment plan)
Stress-related disorders
Sleep disorders (insomnia, sleep maintenance insomnia)
Autoimmune & Inflammatory Conditions
Crohn's disease
Ulcerative colitis
Lupus
Chronic inflammatory disorders
Neurological Conditions
Multiple sclerosis (MS) – Spasticity and muscle spasms
Epilepsy and seizure disorders
Migraines and cluster headaches
Parkinson's disease symptoms
Cancer-Related Symptoms
Chemotherapy-induced nausea and vomiting (CINV)
Appetite loss and weight loss associated with cancer treatment
Cancer-related pain
Gastrointestinal Disorders
Irritable bowel syndrome (IBS)
Inflammatory bowel disease (IBD)
Nausea and vomiting (non-cancer-related)
Product Showcase
Explore our carefully formulated medical cannabis products designed for specific therapeutic needs
Calyxagen CBD 25:1
CBD 25mg/ml | THC 1mg/ml
Potential Clinical Options:
Minimal to non-sedating.
Potential substitute for NSAIDs, Benzodiazepines and help lower opiates.
Preferred 1st line cannabinoid for mild pain and inflammation disorders.
Potential use for anxiety.
Dosing:
10 to 20 mg BID to TID. Initiate 5 to 10 mg HS, then add AM dose in 2 to 3 days.
Some patients up to 30 mg TID.
Highlights:
Not isolate
Minimal amounts of THC added to the high CBD product enhances the clinical response to CBD as demonstrated in studies also known as the "entourage effect".
Calyxagen CBD 10:10
CBD 10mg/ml | THC 10mg/ml
Potential Clinical Options:
Can be sedating
Typical use after trial Calyxagen 25:1 and therapeutic goals not achieved (2nd line)
May be initiated for moderate pain
Potential substitute for NSAIDs, Benzodiazepines, and help lower opiates.
Potential use for anxiety.
Dosing:
Usually start 2.5 mg HS (0.25 ml). 1 hour before bed. Can start 1 mg if patient is very sensitive.
Most patients will not experience a "high" until at least 5 mg.
If no adverse effects and no therapeutic response, increase the dose by 1 to 2.5 mg every 2-3 days based on comfort of the patient.
Usually around 7.5 mg to 10 mg patients should be noticing some improvement or at least sleeping better.
Highlights:
Not isolate
Most common ratio/sku in Canadian cannabis space.
All patients with chronic disease to have CBD on board with THC to reduce side effects, slow down inflammatory disease, and CBD does allow THC to "work" better - allosteric enhancement of the CB 1
Calyxagen 25:5
CBD 5mg/ml | THC 25mg/ml
Potential Clinical Options:
Higher risk of sedation
Not for cannabis naïve patients
Typical use after trial Calyxagen 10:10 and therapeutic goals not achieved (3rd line)
Dosing titration is custom based on patients current therapy and use of other Calyxagen products.
Typical Patient Profile:
Severe pain
High Dose Opiate Users
Additional Pain Control
Chemotherapy Induced Nausea Vomiting
MS Spasticity
Highlights:
Not isolate
Custom designed to a 4:1 THC to CBD ratio.
CBD is incorporated to help reduce inflammation and to allow THC to "work" better – allosteric enhancement of CB1 receptors
Soft Gel Capsule Formulations
Convenient and precise dosing options for diverse patient needs
Soft Gel Capsules
Full Plant Spectrum
(a blend of cannabinoids THC & CBD)
Immediate release soft gelatin capsules
Available in 30 capsule PET bottle
All packaging is Tamper-proof and Child Resistant
Benefits:
Softgels offer a convenient formulation for patients versus measuring a dose with an oral liquid oil. Ideal if a patient requires 1 to 2 softgels per dose.
Softgels will mask the taste from the patient.
Each SKU has a unique individualized colouring for patient identification.
Things to Consider:
Cannabis is very individualized, and dosing can be very patient specific.
Dosing titration may be easier to start with an oral oil until a specific, individualized dose can be achieved and then a conversion to softgel can be considered.
Softgels and Oils can be used together if needed.
Calyxagen 10:10
CBD 10mg : THC 10mg
Potential Clinical Options:
Can be sedating
Typical use after trial Calyxagen 2.5:2.5 softgel and therapeutic goals not achieved (3rd line)
May be initiated for moderate pain
Potential substitute for NSAIDs, Benzodiazepines, and help lower opiates.
Potential use for anxiety
Dosing:
Dosing titration is custom based on patients current therapy and use of other Calyxagen products.
Typical patient dose is 1-2 softgels BID-TID
If patient requires daytime dosing repeat titration in the AM or utilize Calyxagen 25:1 product or Calyxagen 2.5:2.5 if not tolerant to sedation.
Highlights:
Not isolate
Most common ratio/sku in Canadian cannabis space
CBD also mitigates and decreases the THC psychoactive effects.
All patients with chronic disease to have CBD on board with THC to reduce side effects, slow down inflammatory disease, and CBD does allow THC to "work" better - allosteric enhancement of the CB1 receptor
Calyxagen 2.5:2.5
CBD 2.5mg : THC 2.5mg
Potential Clinical Options:
Can be sedating
Typical use after trial Calyxagen 25:1 softgel and therapeutic goals not achieved (2nd line)
May be initiated for mild pain
Potential substitute for NSAIDs, Benzodiazepines, and help lower opiates.
Potential use for anxiety
Dosing:
Usually start 2.5 mg HS (1 softgel). 1 hour before bed.
Most patients will not experience a "high" until at least 5 mg (2 softgels).
If no adverse effects and no therapeutic response, increase the dose by 2.5 mg every 2-3 days based on comfort of the patient.
Usually around 7.5 mg to 10 mg patients should be noticing some improvement or at least sleeping better.
Highlights:
Not isolate
Initiation product for patients requiring THC
CBD also mitigates and decreases the THC psychoactive effects.
All patients with chronic disease to have CBD on board with THC to reduce side effects, slow down inflammatory disease, and CBD does allow THC to "work" better - allosteric enhancement of the CB1 receptor
Vape Formulations
Discreet, fast-acting options for immediate symptom relief
Vape Benefits
Consistent THC & CBD in every vape (vs. dried flower)
1 gram format
80% cannabinoids
Less stigma to other forms of consumption
Pharmaceutical appeal
Commonly used for:
Chronic pain
Sleep disturbances
PTSD
Anxiety
Things to Consider:
Mild to minimal odour
Portable
Convenient & discreet
Vape Products Comparison
| Vape Product | THC Strength | Recommended Use |
|---|---|---|
| Sweet Island Breeze Vape | 31% THC | 1 puff as needed (daytime use, moderate symptoms) |
| Purple Kush Vape | 82% THC | 1 puff at bedtime (severe symptoms, strong sedation) |
Sweet Island Breeze
Perfect for daytime use with mild to moderate symptom relief and functional activity.
Purple Kush
Stronger sedative effects; best reserved for nighttime or severe breakthrough symptoms.
Calyxagen™ Product Line
Complete range of formulations for diverse therapeutic needs
Full-Sized Softgels
Calyxagen 10:10 Softgels
30 capsules
Calyxagen 2.5:2.5 Softgels
30 capsules
Convenient, precise dosing with no taste
Vapes
Purple Kush Vape
1g cartridge • 25% THC
Sweet Island Breeze Vape
1g cartridge • 35% THC
Fast-acting, discreet, minimal odor
Tinctures
Calyxagen 10:10 Tincture
CBD 10mg/ml • THC 10mg/ml
Calyxagen 25:1 Tincture
CBD 25mg/ml • THC 1mg/ml
Calyxagen 25:5 Tincture
CBD 25mg/ml • THC 5mg/ml
Flexible dosing, customizable titration